About
Ricardo is co-founder and Managing Partner of Biovance Capital, a new € 51M fund to invest in early-stage biotech companies across Europe developing innovative therapeutics in all disease areas and drug modalities (small and large molecules, vaccines, cell, and gene therapies). Ricardo is a Harvard and MIT-educated scientist turned investor with experience in scientific research, drug development, venture capital licensing, business development and market analysis. Ricardo has over 18 years of experience in the biomedical sector in USA and Portugal. Prior to Biovance Capital, he was the CEO of Bionova Capital, a venture capital firm that invested in health startups across Europe. At Bionova, he invested in the oncology startup CellmAbs that was sold to BioNTech potentially for more than € 1 billion, the largest-ever biotech deal in Portugal. Ricardo was previously an international business analyst at BIAL, an international R&D-based pharmaceutical company headquartered in Portugal t
Investment Focus
- Stages
- series-a
- Location
- Lisbon, Portugal
Contact Information
Find more investors like Ricardo
Search Investors